Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 02/11/2016 5:21:58 PM
Post# of 72447
Posted By: Slcimmuno
Re: sox0407 #18506
and this is the relevant cite / FN 8 from the last filing

8
Based on the obvious deficiencies (including improper venue), Defendants notified Plaintiff that the complaints were frivolous, were filed without complying with Rule 11’s due diligence obligations, and should be dismissed. Plaintiff declined either to withdraw the complaint, or to undertake efforts with any reasonable diligence to file a properly -supported and -pleaded complaint, within Rule 11’s safe harbor period. Defendants hereby reserve their right to pursue sanctions pursuant to Rule 11’s traditional method, as well as pursuant to the mandatory review process under the PSLRA, which attaches to “any complaint” filed in the matter. 15 U.S.C. §78u-4(c)(1)&2)













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site